Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019-2020? A cross-sectional study in ClinicalTrials.gov
This Excel file contains data used for the research that is described in the manuscript entitled: "Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019-2020? A cross-sectional study in ClinicalTrials.gov" by Amos J. de Jong,1 Renske...
| Main Author: | |
|---|---|
| Language: | unknown |
| Published: |
2022
|
| Subjects: | |
| Online Access: | http://nbn-resolving.org/urn:nbn:nl:ui:13-48-9f6z https://easy.dans.knaw.nl/ui/datasets/id/easy-dataset:254192 |
| Summary: | This Excel file contains data used for the research that is described in the manuscript entitled: "Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019-2020? A cross-sectional study in ClinicalTrials.gov" by Amos J. de Jong,1 Renske J. Grupstra,1 Yared Santa-Ana-Tellez,1 Mira G.P. Zuidgeest,2 Anthonius de Boer,1,3 Helga Gardarsdottir,1,4,5 On behalf of the Trials@Home Consortium61 Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands2 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands3 Dutch Medicines Evaluation Board, Utrecht, the Netherlands4 Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands5 Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland6 trialsathome.comData content: The file contains data on the reporting of decentralised and on-site conduct of predefined trial activities (i.e., participant outreach, pre-screening, pre-screening through medical records, screening, consenting, asynchronous communication with the participant, participant training, investigational medicinal product supply, investigational medicinal product adherence monitoring, clinical trial monitoring, and data collection) and general clinical trial characteristics of the 254 analysed protocols. The methodology and search strategy are explained in the manuscript text. THIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE. TO VIEW A LIST OF FILES AND ACCESS THE FILES IN THIS DATASET CLICK ON THE DOI-LINK ABOVE |
|---|